Literature DB >> 34036373

Protons for the management of adult patients with glioblastoma.

Normand J Laperriere1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34036373      PMCID： PMC8328010          DOI： 10.1093/neuonc/noab121

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  8 in total

Review 1.  Defining Cognitive Reserve and Implications for Cognitive Aging.

Authors:  Corinne Pettigrew; Anja Soldan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-09       Impact factor: 5.081

2.  Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.

Authors:  Linda Douw; Martin Klein; Selene Saa Fagel; Josje van den Heuvel; Martin Jb Taphoorn; Neil K Aaronson; Tjeerd J Postma; W Peter Vandertop; Jacob J Mooij; Rudolf H Boerman; Guus N Beute; Jasper D Sluimer; Ben J Slotman; Jaap C Reijneveld; Jan J Heimans
Journal:  Lancet Neurol       Date:  2009-08-07       Impact factor: 44.182

3.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

4.  Proton radiation therapy for chordomas and chondrosarcomas of the skull base.

Authors:  E B Hug; L N Loredo; J D Slater; A DeVries; R I Grove; R A Schaefer; A E Rosenberg; J M Slater
Journal:  J Neurosurg       Date:  1999-09       Impact factor: 5.115

5.  Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes.

Authors:  Arjun Sahgal; Michael W Chan; Eshetu G Atenafu; Laurence Masson-Cote; Gaurav Bahl; Eugene Yu; Barbara-Ann Millar; Caroline Chung; Charles Catton; Brian O'Sullivan; Jonathan C Irish; Ralph Gilbert; Gelareh Zadeh; Michael Cusimano; Fred Gentili; Normand J Laperriere
Journal:  Neuro Oncol       Date:  2014-12-27       Impact factor: 12.300

6.  Long-term health-related quality of life in pediatric brain tumor survivors receiving proton radiotherapy at <4 years of age.

Authors:  Bree R Eaton; Saveli Goldberg; Nancy J Tarbell; Miranda P Lawell; Sara L Gallotto; Elizabeth A Weyman; Karen A Kuhlthau; David H Ebb; Shannon M MacDonald; Torunn I Yock
Journal:  Neuro Oncol       Date:  2020-09-29       Impact factor: 12.300

7.  A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.

Authors:  Paul D Brown; Caroline Chung; Diane D Liu; Sarah McAvoy; David Grosshans; Karine Al Feghali; Anita Mahajan; Jing Li; Susan L McGovern; Mary-Fran McAleer; Amol J Ghia; Erik P Sulman; Marta Penas-Prado; John F de Groot; Amy B Heimberger; Jihong Wang; Terri S Armstrong; Mark R Gilbert; Nandita Guha-Thakurta; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

Review 8.  Treatment of cognitive deficits in brain tumour patients: current status and future directions.

Authors:  Marijke B Coomans; Sophie D van der Linden; Karin Gehring; Martin J B Taphoorn
Journal:  Curr Opin Oncol       Date:  2019-11       Impact factor: 3.645
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.